242 related articles for article (PubMed ID: 12737622)
21. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.
Danpure CJ
Biochimie; 1993; 75(3-4):309-15. PubMed ID: 8507692
[TBL] [Abstract][Full Text] [Related]
22. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.
Purdue PE; Allsop J; Isaya G; Rosenberg LE; Danpure CJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10900-4. PubMed ID: 1961759
[TBL] [Abstract][Full Text] [Related]
23. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.
Coulter-Mackie MB; Rumsby G
Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418
[TBL] [Abstract][Full Text] [Related]
24. The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1.
Coulter-Mackie MB; Lian Q; Applegarth D; Toone J
Mol Genet Metab; 2005; 86(1-2):172-8. PubMed ID: 15963748
[TBL] [Abstract][Full Text] [Related]
25. Identification of new mutations in primary hyperoxaluria type 1 (PH1).
von Schnakenburg C; Rumsby G
J Nephrol; 1998; 11 Suppl 1():15-7. PubMed ID: 9604803
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.
Danpure CJ; Jennings PR; Fryer P; Purdue PE; Allsop J
J Inherit Metab Dis; 1994; 17(4):487-99. PubMed ID: 7967498
[TBL] [Abstract][Full Text] [Related]
27. The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1.
Coulter-Mackie MB; Applegarth D; Toone JR; Henderson H
Mol Genet Metab; 2004 May; 82(1):64-8. PubMed ID: 15110324
[TBL] [Abstract][Full Text] [Related]
28. Strategies for the prenatal diagnosis of primary hyperoxaluria type 1.
Danpure CJ; Rumsby G
Prenat Diagn; 1996 Jul; 16(7):587-98. PubMed ID: 8843467
[TBL] [Abstract][Full Text] [Related]
29. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case.
Nishiyama K; Funai T; Yokota S; Ichiyama A
J Cell Biol; 1993 Dec; 123(5):1237-48. PubMed ID: 8245128
[TBL] [Abstract][Full Text] [Related]
30. Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype.
Coulter-Mackie MB
Am J Nephrol; 2005; 25(3):264-8. PubMed ID: 15961945
[TBL] [Abstract][Full Text] [Related]
31. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease.
Watts RW
Adv Enzyme Regul; 1992; 32():309-27. PubMed ID: 1496924
[TBL] [Abstract][Full Text] [Related]
32. Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1).
Koul S; Johnson T; Pramanik S; Koul H
Am J Nephrol; 2005; 25(2):176-82. PubMed ID: 15849465
[TBL] [Abstract][Full Text] [Related]
33. Differential enzyme targeting as an evolutionary adaptation to herbivory in carnivora.
Birdsey GM; Lewin J; Cunningham AA; Bruford MW; Danpure CJ
Mol Biol Evol; 2004 Apr; 21(4):632-46. PubMed ID: 14739251
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.
Hopper ED; Pittman AM; Fitzgerald MC; Tucker CL
J Biol Chem; 2008 Nov; 283(45):30493-502. PubMed ID: 18782763
[TBL] [Abstract][Full Text] [Related]
35. Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.
Coulter-Mackie MB; Lian Q
Mol Genet Metab; 2006 Dec; 89(4):349-59. PubMed ID: 16971151
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
[TBL] [Abstract][Full Text] [Related]
37. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.
Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y
J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253
[TBL] [Abstract][Full Text] [Related]
38. Structural implications of a G170R mutation of alanine:glyoxylate aminotransferase that is associated with peroxisome-to-mitochondrion mistargeting.
Djordjevic S; Zhang X; Bartlam M; Ye S; Rao Z; Danpure CJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Mar; 66(Pt 3):233-6. PubMed ID: 20208150
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS
J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142
[TBL] [Abstract][Full Text] [Related]
40. Analyses in transfected cells and in vitro of a putative peroxisomal targeting signal of rat liver serine:pyruvate aminotransferase.
Mizuno T; Ito K; Uchida C; Kitagawa M; Ichiyama A; Miura S; Fujita K; Oda T
Histochem Cell Biol; 2002 Oct; 118(4):321-8. PubMed ID: 12376828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
